Non invasive diagnosis of portal hypertension in cirrhotic patients.
The measure of disease progression in chronic liver disease represents a key challenge in any of the different stages of evolution. Indeed, a correct and reliable measure of the stage of the disease has relevant implications for assessing the effectiveness of the current therapeutic regimens and for predicting the occurrence of complication. Accordingly, a current major effort is directed at evaluating methodologies characterized by no or low invasiveness to be employed as clinical discriminators in patients populations potentially requiring invasive assessment. This appears particularly relevant in patients with compensated cirrhosis, where the only reference standard is the measurement of portal pressure by hepatic venous pressure gradient (HVPG). In this particular context, transient elastography (TE) appears to be promising and needs to be further investigated, possibly in combination with other non-invasive methodologies such as serum markers algorithms and/or imaging techniques. On the other hand, the application of non-invasive methods for monitoring the response to vasoactive treatment for the reduction of portal pressure and the prevention of related complications seems at the moment not realistic.
Vizzutti
F
F
Dipartimento di Medicina Interna, Università degli, Studi di Firenze - Azienda Ospedaliero Universitaria Careggi, Firenze, Italy.
Arena
U
U
Rega
L
L
Pinzani
M
M
D006801:Humans; D006975:Hypertension, Portal / Q000175:diagnosis* / Q000209:etiology*; D008103:Liver Cirrhosis / Q000150:complications*